期刊文献+

早发性卵巢功能不全患者肥胖及糖脂代谢特征 被引量:2

The Characteristics of Obesity and Glycolipid Metabolism in Premature Ovarian Insufficiency Patients
下载PDF
导出
摘要 目的:探讨早发性卵巢功能不全(POI)患者肥胖及糖脂代谢特征。方法:选取2018年1月—2019年6月在首都医科大学附属北京妇产医院内分泌科就诊的POI患者102例,平均年龄(30.34±4.73)岁,选择同期年龄匹配的正常对照组68例,平均年龄(30.76±4.69)岁,记录研究对象的年龄、月经情况,测量其身高、体质量、腰围、臀围,测定血清基础卵泡刺激素(FSH)、黄体生成激素(LH)、雌二醇(E2)、空腹血糖(FPG)、空腹胰岛素(FINS)、三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-c)和低密度脂蛋白胆固醇(LDL-c)。对POI组及正常对照组的各项指标进行比较。结果:①POI患者臀围高于正常对照组(P=0.016),2组间其他人体测量指标比较差异均无统计学意义(P>0.05)。②POI组与正常对照组全身型肥胖率(27.4%vs.23.5%)及腹型肥胖率(33.3%vs.33.8%)比较差异均无统计学意义(P>0.05)。③POI组TG、LDL-c及FINS均高于正常对照组(P<0.05),2组间TC、HDL-c、FPG及HOMA-IR比较差异无统计学意义(P>0.05)。结论:POI患者肥胖率与正常对照组相似,而部分糖脂代谢指标不同于年龄匹配的正常人群,临床工作中对POI患者诊疗时应进行全面评估。 Objective:To explore the characteristics of obesity and glycolipid metabolism in premature ovarian insufficiency(POI)patients.Methods:102 POI patients with age 30.34±4.73 years and 68 healthy age-matched women(control group)with age 30.76±4.69 years,who came to Department of Gynecological Endocrinology in Beijing Obstetrics and Gynecology Hospital between January 2018 and June 2019,were recruited.Age and menstruation of these patients were recorded.Body height,body weight,waist circumference,hip circumference,basal follicle stimulating hormone(FSH),luteinizing hormone(LH),estradiol(E2),fasting plasma glucose(FPG),fasting insulin(FINS)and blood lipids(total cholesterol,triglyceride,high density lipoprotein-cholesterol and low density lipoprotein-cholesterol)were measured.The indices between POI patients and control group were compared.Results:①The hip circumference of POI patients was higher than control group(P=0.016).But there were no significant differences in other anthropometric indices between the two groups(P>0.05).②The comparison of the prevalence of overall obesity(27.4%vs.23.5%)and abdominal obesity(33.3%vs.33.8%)between POI patients and control group had no significant differences(P>0.05).③The level of TG,LDL-c and FINS in POI patients were higher than control group(P<0.05).While there were no significant differences in TC,HDL-c,FPG and HOMA-IR between the two groups(P>0.05).Conclusions:The prevalence of obesity in POI patients was similar to control group.While some of the glycolipid metabolism indices are different between POI patients and control group.So it is necessary to give a comprehensive assessment of POI patients in clinical work.
作者 金婧 阮祥燕 华琳 王月姣 李扬璐 JIN Jing;RUAN Xiang-yan;HUA Lin;WANG Yue-jiao;LI Yang-lu(Department of Gynecological Endocrinology,Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing 100026,China;Department of Bioinformatics,Capital Medical University,Beijing 100069,China)
出处 《国际妇产科学杂志》 CAS 2020年第5期508-511,共4页 Journal of International Obstetrics and Gynecology
基金 北京市属医院科研培育计划(PX2017053) 中国国际人才交流基金会(2018042000002)。
关键词 早发性卵巢功能不全 肥胖症 葡萄糖代谢障碍 血脂异常 胰岛素抗药性 Premature ovarian insufficiency Obesity Glucose metabolism disorders Dyslipidemias Insulin resistance
  • 相关文献

参考文献7

二级参考文献42

  • 1da Silva HG, Mendonca LM, Conceicao FL,et al.lnfluence of obesity on bone density in postmenopausal women. Arq Bras Endocrinol Metabol. 2007, 51(6):943-949.
  • 2Tufano A, Marzo P, Enrini R, etaI.Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause. J Endocrinol Invest.2004;27:648-653.
  • 3Gaspard U.HyPerinsulinaemia,a key factor of the metabolic syndrome in postmenopausal women. Maturitas. 2009;6. [Epub ahead of print].
  • 4ChedrauiP, Hidalgo L,Chavez D,et al. Quality of life among postmenopausal Ecuadorian women participating in a metabolic syndrome screening program. Maturitas.2007;56(1 ):45-53.
  • 5Ding QF, Hayashi T,Zhang XJ,et al. Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopausal women. J Diabetes Complications.2007;21 (5):315-319.
  • 6Cho GJ, Lee JH, Park HT, et al. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause. 2008; 15(3):524-529.
  • 7Cameron AJ, Magliano D J, Zimmet PZ, et aI.The Metabolic Syndrome in Australia: Prevalence using four definitions. Diabetes Research and Clinical Practice.2007; 77(3):471-478.
  • 8Rossi R,Nuzzo A,Oriqliani G, et al. Metabolic syndrome affects cardiovascular risk profile and response to treatment in hypertensive postmenopausal women, Hypertension. 2008;52(5):865-872.
  • 9Llaneza P, Gonzalez C, Fernandez-Inarrea J,et al. Insulin resistence and health-related quality of life in postmenopausal women. Fertil Steril.2008;16. [Epub ahead of print].
  • 10Alberti KG, Zimmet PZ, shaw JE. The metabolic syndrome a new world-wide definition from the International Diabetes Federation consensus. Lancet. 2005; 183(4): 175-176.

共引文献661

同被引文献16

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部